Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
  • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
  • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
  • B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
  • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
  • B01L3/502746—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
  • B01L2200/06—Fluid handling related problems
  • B01L2200/0642—Filling fluids into wells by specific techniques
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
  • B01L2200/06—Fluid handling related problems
  • B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0809—Geometry, shape and general structure rectangular shaped
  • B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0809—Geometry, shape and general structure rectangular shaped
  • B01L2300/0819—Microarrays; Biochips
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0848—Specific forms of parts of containers
  • B01L2300/0851—Bottom walls
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2400/00—Moving or stopping fluids
  • B01L2400/08—Regulating or influencing the flow resistance
  • B01L2400/084—Passive control of flow resistance
  • B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2400/00—Moving or stopping fluids
  • B01L2400/08—Regulating or influencing the flow resistance
  • B01L2400/084—Passive control of flow resistance
  • B01L2400/088—Passive control of flow resistance by specific surface properties

Definitions

• the present invention relates to a microfluidic process for handling samples, in particular biological samples, in hydrogel microdrops.
• the invention also relates to a device for implementing such a method and to a product of samples obtained by implementing such a method.
• hydrogel microbeads including cells are made in a first microfluidic system. They are then recovered and washed in a bath, before being injected into a second microfluidic system comprising traps for fixing the microdrops.
• Such a method is however complex, which requires two separate microfluidic systems and three devices in total. In addition, it does not allow to observe the samples continuously. In particular it does not allow to observe the initial moments between the formation of the drops and their capture.
• the invention provides a method of handling in a microfluidic system of microdroplets including samples, comprising the steps of:
• microdrops of interest that is to say the microdrops which contain samples of interest - these microdroplets are first trapped in surface tension traps (or traps capillary), then some of the microdroplets and / or part of the oil surrounding them are gelled. Gelation of microdrops and / or oil around them facilitates sorting by increasing the trapping force of microdrops in traps. In other words, the gelling step makes it possible to prevent microdrops of interest from being lost.
• surface tension trap is meant a trap a zone of the microfluidic system whose geometry, with the interfacial tension of the microdrop, allows the microdrop to be held in position.
• Microfluidic system means a system whose parts are manufactured by micro-manufacturing processes. Such a system has ducts of which at least one dimension is typically less than one millimeter.
• the shape of the microdrop can be controlled. This control of the shape of the microdrop can be combined with the control of the instant of gelation of the microdrop or part of the oil surrounding it, to give access to different applications, in particular on the manipulation of cells .
• cells are meant eukaryotic cells (for example plant cells, fungi, yeasts, mammalian cells) and prokaryotic cells (for example bacteria).
• eukaryotic cells for example plant cells, fungi, yeasts, mammalian cells
• prokaryotic cells for example bacteria.
• anchorage-independent cells for example, certain cells in the blood line and highly transformed tumor cells
• anchorage-dependent cells the majority of other cell types
• spheroids means multicellular structures organized in the form of micro-tissues whose functionalities are similar to those of tissues derived from organs.
• the method according to the invention comprises one or more of the following characteristics, taken alone or in combination:
• step iii) comprises gelling at least a portion of the oil in the trapping area, excluding microdrops;
• step iii) comprises gelling at least a portion of the microdroplets, excluding the oil surrounding the microdroplets in the trapping area;
• the sample is one of one or more cells, in particular a spheroid of cells, one or more beads trapping molecules, the balls being in particular of plastic material, one or more molecules;
• step iii) is carried out after sedimentation of the samples, in particular cells, in the trapped microdroplets, in particular after formation of spheroids;
• step iii) is carried out before sedimentation of the samples in the trapped microdroplets;
• the method further comprises the step of:
• the aqueous solution replacing the oil contains a biochemical solution
• the biochemical solution preferably comprising at least one of one or more pH or salinity buffers, one or more nutrients, one or more growth factors, cytokines, a or antibodies, one or more antigens, one or more molecules, in particular of drug, one or more cells, lipids, carbohydrates, in particular in monomeric form or of polysaccharides, amino acids and / or proteins;
• the trapping area is formed by a microfluidic chip comprising the surface tension traps
• step i) consists of:
• steps i) and ii) are performed simultaneously in the trapping area, performing the actions of:
• step iii) consists of at least one of:
• the oil contains a surfactant, the process preferably comprising a step of washing the surfactant prior to step iv);
• the method comprises a step, prior to step i), of choosing the shape of the surface tension traps according to the desired shape of the microdroplets;
• the trapping area and traps are chosen for:
• the process comprises a step v) subsequent to step iii), and preferably subsequent to step iv), of thawing at least some of the gelled microdroplets in step iii);
• the method comprises a step vi), subsequent to step v), consisting in discharging the degelified microdroplets and / or the samples contained in these degelified microdroplets outside the trapping zone;
• the method comprises a step of applying a stimulus to the samples contained in at least a portion of the entrapped microgout, gelled or not;
• the method comprises a step subsequent to step iii) of pushing out of the trapping zone the microdroplets around which the oil has not been gelled, to keep in the trapping area only the microdroplets around which the oil has been gelled.
• the invention relates to a device for implementing a method as described above in all its combinations, comprising:
• a trapping zone in particular a microfluidic chip, for trapping microdrops at predetermined locations
• the gelation means may comprise a device for injecting a chemical agent into the trapping zone.
• the device may further comprise means for de-thawing at least some of the gelled hydrogel microdroplets and / or a portion of the gelled oil.
• the invention also relates to a product of gelled microdroplets, comprising a trapping area for microdroplets, in particular a microfluidic chip, and gelled microdroplets each including a sample, trapped in the trapping zone, the gelled microdroplets preferably being cryo-preserved .
• the biochemical solution may contain cryo-protection agents (DMSO, glycerol, trehalose, etc.) to allow cryo-preservation of the samples.
• cryo-protection agents DMSO, glycerol, trehalose, etc.
• the gelled microdroplets may also be immersed in a fluid, preferably in an aqueous solution or in an oil, the fluid and microdrops being preferably cryo-preserved.
• the invention also relates to a microdrop product, comprising a trapping zone, in particular a microfluidic chip, and microdrops each including a sample, trapped in the trapping zone, the microdroplets bathed in a gelled oil, the microdroplets and the microdroplet.
• gelled oil being preferably cryo-preserved.
• the samples may be mammalian cells, preferably mammalian cells excluding human cells, bacteria, yeasts or other cells used in bioprocesses, molecules, beads trapping molecules on the surface.
• FIG. 1 schematically represents a microfluidic chip
• FIG. 2 diagrammatically represents the microfluidic chip of FIG. 1, where traps are occupied by a hydrogel microdroplet containing samples
• FIG. 3 diagrammatically represents the microfluidic chip of FIG. 1 containing a mixture of hydrogel and samples to be tested
• FIGS. 4 to 6 schematically illustrate a means of evacuating a portion of the samples contained in hydrogel microdroplets trapped in a microfluidic chip, outside this microfluidic chip,
• FIGS. 7 to 12 schematically illustrate examples of geometries of surface voltage traps and the forms of microdroplets that they make it possible to obtain
• FIGS 13 to 15 schematically illustrate examples of sedimentation of samples in hydrogel microdroplets.
• the invention relates to a method of handling hydrogel microdroplets including test samples.
• the method essentially comprises three steps, all implemented in a single microfluidic system, the three steps of:
• the aqueous solution is a hydrogel solution
• the oil does not comprise a gelling agent and where the last step above is to gel at least a portion of the microdroplets trapped, without the oil being gelled.
• the method can be continued by implementing different steps, depending on the test that is to be implemented, in particular.
• the method may in particular be continued by a step consisting in replacing the oil around the gelled microdroplets with an aqueous solution, without moving the microdroplets of the surface tension traps.
• the aqueous solution may contain a biochemical solution with at least one of nutrients, growth factors, antibodies, drug molecules and buffers of pH and / or salinity.
• the method allows the control of the three-dimensional shape of hydrogel beads in a microfluidic channel and / or in surface tension traps, with for first application the encapsulation of cells in these microdroplets.
• the encapsulation of the cells in the hydrogel allows their culture or analysis, while perfusing them with biochemical solutions, or by applying to them physical stimuli such as heat or light, for example.
• Gel means a medium composed of a majority of liquid and containing molecules or particles that can be organized to give it a solid appearance, such as the absence of flow in its stable state. This solution can be handled in the liquid state and can then be “gelled” by chemical or physical means. Gelification can be reversible in some cases. When the liquid is water, it is called hydrogel.
• the proposed microfluidic process comprises a first step of forming hydrogel microdroplets containing biological cells in an oil.
• the microdrops (or microbeads) have a diameter of about one micrometer, in particular a diameter of between 10 and 1000 microns.
• the hydrogel is, for example, an aqueous solution comprising a gelling agent.
• the gelling agent is chosen by the user according to the application.
• An example of a gelling agent that can be physically gelled is agarose, which is liquid at room temperature and gels at a low temperature.
• a gelling agent that can be chemically gelled is, for example, alginate, which is liquid in solution and which gels when calcium ions Ca 2+ are added .
• the biochemical and biomechanical properties of the hydrogel may allow anchor-sensitive cells to establish specific interactions with the thus-formed matrix. These interactions are essential for the survival of anchorage-dependent mammalian cells and participate in the regulation of their phenotype.
• the nature of the matrix may, for example, make it possible to observe cell migration or proteolysis (digestion of the matrix by the cells).
• agarose, Palginate, PEG-DA (Polyethylene glycol Diacrylate) but also gelatin, collagen type I or Matrigel ®.
• hydrogels containing various proteins, glycoaminoglycans and other components of the extracellular matrix have demonstrated their ability to maintain viability, support proliferation and ability to migration, as well as to maintain the phenotype of some anchorage-dependent cell populations.
• the gels can be combined, for example by adding microdrops. To each of the hydrogels mentioned is a specific gelation procedure.
• hydrogels such as PEG-DA
• may further be functionalized to allow cell survival and / or development by incorporating peptidomimetics eg hydrogels may be functionalized with RGD-type consensus sequences upon which certain cell types Mammals can establish specific interactions or PRCG [V / N] PD or HEXGHXXGXXH consensus sequences specific to metallo proteases) or the specific molecule sensor via the incorporation of antibodies or aptamers, for example in situ capture of cytokines secreted by encapsulated lymphocytes.
• the mechanical properties of these hydrogels can also be modulated for different applications, for example by varying their degree of crosslinking and / or concentration.
• All of these physicochemical properties may differ from one trap to another within the trapping area.
• the introduction of a rigidity gradient within the trapped hydrogel microgout allows, for example, the controlled differentiation of stem cells into different cell types.
• several hydrogels can coexist in the same microdrop following a mixture or the successive formation of several layers around the gelled heart in the trap.
• the cells are mixed with the hydrogel, prior to the formation of the microdrops.
• the mixture of the hydrogel and the cells can be made directly in the microfluidic device, before the formation of microdrops.
• microdroplets After forming these microdroplets, the microdrops are transported from the zone where they were formed to the trapping zone by microchannels, driven by an oil flow and / or by slopes or rails. This routing has been found to aid in the formation of spheroids in microdrops.
• the microdroplets are then trapped by surface tension traps placed in the trapping area, in particular in a microfluidic chip.
• the trapping area (or microfluidic chip 10) is treated with a hydrophobic surface treatment and filled with an oil containing a surfactant.
• surfactant allows the stabilization of microdrops and the reproducibility of their formation.
• the surfactants also make it possible to prevent the microdroplets from coalescing if they come into contact during their transportation from the production device to traps in the trapping area.
• the microfluidic chip 10, as illustrated in FIG. 1, is composed of a culture chamber, possibly several square centimeters, containing numerous surface tension traps organized in a table or matrix.
• the surface tension traps 12 may have various shapes. For example, in the case of cylindrical traps, their diameter may range from a few tens of microns to several hundred depending on the desired application. For the encapsulation of single or individualized cells in microdrops, the diameter of the traps may be for example 50 microns, which corresponds to a density of about 5000 traps per square centimeter. For the study of large cell aggregates or spheroids, this diameter can increase to 250 microns, which corresponds to a trap density of about 250 traps per square centimeter. As illustrated in FIG. 1, the microdroplets 14 including the biological cells 16, formed outside the microfluidic chip 10, are entrained in the latter, for example by means of an oil flow illustrated by the arrow 18 so that some of these microdroplets are trapped in the surface tension traps 12.
• hydrogel microdrops containing biological cells in an oil, without precise control of the hydrogel flow containing the biological cells in the oil. Indeed, only the microdroplets having adequate dimensions are subsequently trapped in the trapping area, so that the latter is occupied by microdroplets finally having a high homogeneity in size, shape and concentration of biological cells.
• the trapping zone in particular a microfluidic chip 10, contains a hydrogel solution 20 containing biological cells 16.
• the oil trapping zone is then injected into the trapping zone. injection is shown schematically by arrow 18), which pushes the hydrogel solution containing biological cells 16 to an exit of the trapping area.
• the microdroplets then form directly at the level of the surface tension traps 12, by trapping the hydrogel in these traps of the microfluidic chip, until a configuration substantially identical to that illustrated in FIG. thus form by spontaneous division (or breakage) of the hydrogel solution containing the biological cells, on the surface tension traps.
• the traps may be of very different shapes, in particular depending on the desired application, that is to say in particular depending on the shape of the trapped microgout sought.
• the trap cavity can also be indifferently on the upper wall, bottom or one of the side walls of the trapping area, in particular the microfluidic chip.
• FIGS. 7 to 12 illustrate possible forms of the surface tension traps 12 of the microfluidic chip 10 and the shape of the microdroplets 14 which can be obtained using these surface tension traps 12.
• the shape of the trap 12 makes it possible to control the shape of the trapped microdroplets, according to the geometrical parameters of the microfluidic channel in which the trap 12 is formed, and the volume of the trapped microdroplets.
• FIG. 7 schematically illustrates the parameters to be taken into account in order to determine the profile of the microdrop, namely the radius R of the microdrop confined in a channel containing a trap 12, the height h of this channel, less than the radius R of the microdrop in the channel, and the diameter d and the depth p of the trap 12.
• the microdrop 14 When the trap 12 is cylindrical and has a diameter d greater than twice the height h of the channel, as illustrated in FIGS. 8 to 10, then the microdrop 14 returns as much as possible to the trap 12.
• the microdrop 14 may or may not have a hemispherical cap, and have or not a flat portion, confined by the walls of the channel.
• the volume of the microdrop 14 is greater than the volume of the trap 12. In this case, the microdrop 14 fills the trap 12 almost completely and has a flattened shape against the walls of the channel and the trap.
• the microdrop 14 has a slightly smaller volume than that of the trap 12, while the microdrop 14 has two hemispherical caps and only scratches the walls of the channel. Finally, if the microdrop 14 has a much smaller volume than the volume of the trap 12, as illustrated in FIG. 10, then the microdrop 14 (or even several microdroplets 14) are entirely received in the trap 12.
• the trap has a diameter d less than twice the height h of the channel.
• the microdrop 14 remains essentially confined in the channel and has only a small hemispherical cap in the trap 12.
• the trap 12 is conical and has a diameter d greater than twice the height h of the channel.
• the microdrop 14 then marries the shape of the wall of the trap 12 to form a hemispherical cap in the trap 12.
• the cells 16 sediment and settle statistically uniformly at the bottom of the microdrop 14. The cells can then be observed individually, and do not aggregate.
• the microdrop 14 trapped in a trap 12 has a non-flat bottom, in particular a convex bottom, as illustrated in FIGS. 14 and 15, then the cells 16 meet the interface of the microdrop 12 during their sedimentation, and meet again have to slide along this interface.
• the cells 16 focus thus at the bottom of the microdrop 14, and may eventually aggregate and form spheroids in the case of certain cells dependent on the anchor.
• the microfluidic process proposed here comprises, after the entrapment of the microdroplets, a step of gelation of these microdrops.
• the hydrogel contains, preferably is agarose.
• the gelation of the microdroplets is then carried out by cooling the microfluidic chip.
• the hydrogel contains or, preferably, is alginate, it is possible to bring calcium ions Ca 2+ into the oil in which the microdots are immersed, or to pre-mix calcareous particles with the alginate and saturate in C0 2 the oil in which the microdroplets bathe. The alginate is thus acidified and calcium ions are released.
• other gelling agents may be used, other means of gelation can be implemented.
• this gelation step may be carried out at different times of the handling method.
• the gelation can be done immediately after the trapping so as to freeze the cells in situ, in the microdrop, and not allow them to sediment. The cells can then be observed independently of one another.
• the gelation is carried out after the sedimentation of the cells to form spheroids. This makes it possible to observe the behavior of the cells having formed a spheroid.
• gelation of the microdroplets is implemented only after manipulation of the cells in a liquid medium, for example to extract certain cells - those in ungelled microdroplets - selectively. This may be useful for cells such as bacteria or erythrocytes and leucocytes, which are independent of anchorage.
• aqueous solution containing in particular a biochemical solution comprising biochemical components such as nutrients, growth factors, antibodies, drugs or drug molecules, for example.
• biochemical components such as nutrients, growth factors, antibodies, drugs or drug molecules, for example.
• biochemical components diffuse into the gel and reach the cells. It is thus possible to study the reaction of cells, independent or in the form of spheroids, with these stimuli.
• the hydrogel thus keeps the cells in a precise location, while allowing their infusion by an aqueous phase and having previously compartmentalized the biological sample during encapsulation of cells in microdrops.
• the surfactant from the interfaces of microdrops.
• the shell formed by the surfactants at the interface of the microdroplets can indeed be so effective that it prevents the aqueous phase, which is injected to replace the oil, to fill the micro fluidic chip, keeping the microdroplets gelled in their respective traps.
• the arrival of the interface of the aqueous phase at a trap results in a force applied to the gelled microgout which can be removed from the trap if the hydrogel which composes it is sufficiently compressible. Therefore, it is preferable to promote coalescence by decreasing the concentration of surfactant at the interface.
• the micro fluidic chip is perfused before injection of the aqueous phase with oil which, unlike the oil used previously, does not contain surfactant.
• concentration of surfactant in the oil of the microfluidic chip decreases, which makes it possible to shift the surfactant adsorption balance at the interface towards the desorption.
• concentrations of surfactant for example of the order of a few percent by weight, it is preferable to infuse the microfluidic chip with an amount of oil equivalent to 50 times the volume of the microfluidic chip. This ratio depends on the nature of the surfactant (s) and its affinity for both phases.
• the shape of the traps can also be optimized to maintain the position of gelled microdroplets in the traps.
• the height of the channel is greater than the radius of the trap, the entry of the microdrop into the trap will be minimal, resulting in a low trapping efficiency.
• the microdrop when the channel height is smaller than the trap radius, the microdrop, provided it is large enough, penetrates strongly into the trap cavity, resulting in a high trapping efficiency. The microdrops remain in place regardless of the speed of the external flow.
• the shape of the microdrop is very close to its shape in the channel while in the second case, it adopts locally the shape of the trap.
• the gelling agent of the chosen hydrogel is reversible, it is possible to defrost the microdrops and then to evacuate their contents out of the microfluidic chip, as illustrated in FIGS. 4 to 6.
• the microdroplets 14 are gelled agarose microdrops, for example. These microdroplets 14 of agarose are de-lined one by one by heating them locally (the heating being illustrated by flashes 21), in particular using an infra-red laser or electrodes. Heat liquefies agarose.
• the phase surrounding the microdroplets 14 is aqueous
• the content 16 of the degelified agarose mixes with the aqueous phase. It is then possible to entrain this content by the stream 22 of the aqueous phase, possibly to recover it. It is also possible to eliminate the cells considered as non-interesting microfluidic chip 10.
• the shape and size of the trap are preferably chosen to allow the extraction of cells. For example, in the case where the cells must remain viable, the trap is sized large enough that the heating of the hydrogel does not induce the mechanisms of cell death does not induce the mechanisms of cell death.
• the phase surrounding the microdrops is oily
• an oil flow may be imposed to dislodge the liquid microdrop from the trap.
• the shape and the force of the trap are preferably dimensioned so as to allow the extraction of the selected microdroplet only, and not others. This sizing depends in particular on the value of the surface tension between the aqueous phase and the oil, as well as the rigidity of the gel microdroplets and their shape inside the trap.
• Another alternative is to maintain liquid microdrops for handling suspended cells, for example bacteria. Gelification is then carried out only for the selective extraction of microdrops. In this case, one can either gel all microdrops before extraction and apply the protocol described above, or on the contrary only gel microdrops that want to keep in the traps.
• the process presented makes it possible, thanks to slight modifications, to be interested in very varied biological applications.
• the device can of course also be modified by adjusting the height of the channel in the microfluidic chip and the geometry of the traps.
• rapid gelation with low cell concentration makes it possible to individualize a few unique cells in each microdrop while trying to limit their direct interactions.
• These cells may for example be bacteria, yeasts or mammalian cells.
• a high concentration of cells with always rapid gelation allows to obtain a large number of cells always individualized but close to each other.
• the cells may however be kept encapsulated for a long time in the liquid phase before gelation.
• a low concentration of cells then makes it possible, for example, to study cells in suspension, independent of the anchoring, such as lymphocytes.
• a high concentration of cells and a form of trapped microdroplets allowing the sedimentation of the cells makes it possible to put in contact the cells which will be able to be reorganized into spheroids.
• the method can also make it possible to form spheroids directly in the chip in a controlled manner.
• the volume of the microdroplets created can be controlled by the microdrop formation device upstream of the microfluidic chip. This volume is preferably adjusted so that the microdrops, once trapped, have a diameter equal to that of the trap and a spherical shape. To do this, the depth of the trap is preferably at least equal to its diameter. The fact that the diameter of the trapped microgout coincides with that of the trap makes it possible to ensure a high trapping efficiency.
• the spherical shape promotes the formation of spheroids.
• the microdrops preferably contain cells in suspension in an aqueous phase comprising or consisting of culture medium and hydrogel.
• the external oil flow is stopped, which stops the recirculation within microdroplets and promotes sedimentation of the cells.
• the spherical shape of the microdrops in the traps then induces a concentration of the cells at their lowest points until they come into contact. Keeping the chip at rest, under conditions favorable to the survival and proper metabolic function of the cells, especially in temperature, for a period ranging from several hours to several days, allows the reorganization of the concentrated cells at the bottom of the trapped microgout, as a spheroid.
• the time required for the formation of spheroids may in particular depend on the cell type used and the composition of the hydrogel. For H4IIEC3 rat liver cells in a 1% mass agarose solution diluted in culture medium, this duration was found to be less than 24 hours. Of course, the hydrogel is kept liquid during the formation time of the spheroids.
• the size of the spheroids is given by the number of cells encapsulated in each microdrop and therefore by the concentration of the cell solution injected into the microfluidic chip.
• the distribution of the number of cells per microdroplet, and therefore that of the size of the spheroids formed, is very homogeneous provided that the cells are sufficiently individualized at the time of injection.
• 98% of the traps were filled with a liquid agarose microdroplet which after 24 hours of incubation contained a well-reorganized spheroid.
• the spheroids obtained in the micro fluidic chip can be kept in culture for several days.
• spheroids of H4IIEC3 cells encapsulated in agarose can be cultured in the flea for a week without significantly impairing their viability while retaining strong functionality (in this example a strong and continuous albumin secretion).
• the method presented here and the microfluidic chip obtained by implementing it, constitute an excellent tool for screening drugs.
• the high efficiency of the formation process of these spheroids also makes it possible to create a large number from very limited samples. 500 spheroids of about 70 ⁇ in diameter can thus be formed with only 100,000 cells.
• the cells that make up the spheroids can also be of different types to address themes of co-culture. These cell types can be homogeneously mixed in solution before injection into the chip or be arranged according to a certain structural organization, in several layers of successive hydrogels or simply by adhesion to the hydrogel after being perfused into the external aqueous phase.
• fibroblasts and epithelial cells can be combined to form a skin model and to test the toxicity of cosmetic products, neurons and astrocytes to model the brain, or endothelial cells and smooth muscle cells as in the wall of the skin. blood vessel.
• the method presented here achieves very advanced control of the microenvironment of cells in culture, it is also an excellent tool for the study of stem cell differentiation.
• the encapsulated cells may indeed be subjected to a whole range of concentration of differentiating factors and, potentially at the same time, to a whole range of rigidity of the matrix, for example by adjusting the concentration of the hydrogel.
• the method can be used to observe the embryonic development over time in interaction with the physicochemical factors of the external environment.
• this method makes it possible to make a medical diagnosis based on the response of the cells to certain markers.
• the cells are captured with a very low rate of losses.
• the cells can then be subjected to known diagnostic tests for certain diseases, such as a characterization of a cancerous biopsy.
• PCR polymerase chain reaction
• FISH FISH method.
• the expression of specific proteins can also be detected by labeling methods, for example by providing antibodies for immuno-labeling or for an enzyme immunoassay method ELIS A (Enzyme-Linked ImmunoSorbent Assay). in situ.
• the process described above offers the possibility of carrying out all the analysis and cell culture steps in a microfluidic chip, thanks to the gelation of the microdroplets following their trapping in the chip. This makes it possible to use much smaller volumes of reagents than for tests carried out in multiwell plates or in culture dishes. This also allows tracking of cell responses over time, following different stimuli.
• hydrogel microdrops containing cells means for forming hydrogel microdrops containing cells, a trapping zone, in particular a microfluidic chip, for trapping the hydrogel microdroplets at predetermined locations, and
• the gelation means comprise, for example, a device for injecting a chemical agent into the trapping zone and / or temperature control means, for example for cooling the microfluidic chip.
• the device may also include means for de-thawing at least some of the gelled hydrogel microdroplets, for example a laser.
• a gelled microdrop product comprising a microdrop trapping zone, in particular a microfluidic chip, and gelled microdroplets each including one or more cells trapped in the trapping zone, the microdroplets.
• gelled are preferably cryopreserved.
• Cells can be aggregated as clusters or spheroids.
• the gelled microdroplets may be immersed in a fluid, preferably in an aqueous solution or in an oil, the fluid and microdrops being preferably cryo-preserved. This cryo-preservation allows in particular the maintenance of the cells under stable conditions for a long time, with a view to transporting them or storing them for later analysis.
• the biological cells encapsulated in the microdroplets may be bacteria, yeasts, eukaryotic cells, mammalian cells, preferably mammalian cells excluding human cells, more preferably rat or other mammalian cells. , or human cells isolated from their natural environment.
• samples used in addition to cells, may in particular also be molecules, functionalized plastic beads by coupling them to molecules.
• the trapped microdroplets can be fused with other microdrops made by the aqueous solution stream.
• the aqueous solution of which the microdrops are constituted may contain a biochemical solution, the biochemical solution preferably comprising at least one of lipids (fatty acids, etc.), carbohydrates (in monomeric form or polysaccharides, etc.). ), amino acids and proteins (growth factors, cytokines, antibodies, antigens etc.), as well as salinity and / or pH buffers.
• the oil (or oily phase) surrounding the microdroplets may contain fluorinated oils (FC40 type) or water-immiscible photo-crosslinkable solutions (Norland Optical Adhesive type), which once polymerized to gel the oil and thus physically and selectively isolate microdrops. It is thus possible to partition, isolate in a more robust manner, the microdrops with respect to each other. This prevents two microdrops merge, causing a mixture of the samples they contain. This also makes it possible to store the samples in a sustainable manner, the risks of evaporation, in particular, microdroplets being greatly reduced due to the partitioning of the microdroplets by the gelled oil, which forms a solid compartment around the microdroplets.
• FC40 type fluorinated oils
• Norland Optical Adhesive type water-immiscible photo-crosslinkable solutions
• the microdroplets around which the oil has not gelled can be pushed out of the trapping zone. To do this, it is possible to implement a flow of oil or another fluid in the trapping zone, the flow being sufficiently strong to drive the microdroplets. It is thus possible to keep in the trapping zone only the microdrops around which the oil has been gelled.
• microdrops can be gelled even in the case where the oil is gelled.
• the process may of course include in this case where a part of the oil is gelled, a subsequent step of degelling the gelled oil.

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Dispersion Chemistry (AREA)
• Analytical Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Hematology (AREA)
• Clinical Laboratory Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Colloid Chemistry (AREA)
• Sampling And Sample Adjustment (AREA)

Applications Claiming Priority (1)

Publications (2)

Family

ID=51897384

Family Applications (1)

Country Status (6)

Families Citing this family (18)

Family Cites Families (20)

• 2014
  • 2014-10-17 US US15/519,574 patent/US10710077B2/en active Active
  • 2014-10-17 WO PCT/FR2014/052655 patent/WO2016059302A1/fr active Application Filing
  • 2014-10-17 ES ES14796828T patent/ES2856733T3/es active Active
  • 2014-10-17 JP JP2017520412A patent/JP2017537772A/ja active Pending
  • 2014-10-17 CN CN201480082752.5A patent/CN107109319B/zh active Active
  • 2014-10-17 EP EP14796828.3A patent/EP3206791B1/de active Active

Also Published As

Similar Documents

Legal Events